APA (7th ed.) Citation

Jagan, S., Paganessi, L. A., Frank, R. R., Venugopal, P., Larson, M., & Christopherson, K. W. Bone Marrow and Peripheral Blood AML Cells Are Highly Sensitive to CNDAC, the Active Form of Sapacitabine. Wiley.

Chicago Style (17th ed.) Citation

Jagan, Sucheta, Laura A. Paganessi, Robin R. Frank, Parameswaran Venugopal, Melissa Larson, and Kent W. Christopherson. Bone Marrow and Peripheral Blood AML Cells Are Highly Sensitive to CNDAC, the Active Form of Sapacitabine. Wiley.

MLA (9th ed.) Citation

Jagan, Sucheta, et al. Bone Marrow and Peripheral Blood AML Cells Are Highly Sensitive to CNDAC, the Active Form of Sapacitabine. Wiley.